Pituitary-Adrenal Function After Prolonged Glucocorticoid Therapy for Systemic Inflammatory Disorders: An Observational Study
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
CONTEXT: Glucocorticoid therapy is being used in a wide variety of systemic disorders. Reference papers, published more than 20 years ago, showed no correlation between adrenal insufficiency risk and dose or duration of glucocorticoid therapy. OBJECTIVE: Our objective was to evaluate the extent to which long-term glucocorticoid therapy damages the pituitary-adrenal axis in patients with systemic inflammatory disorders. DESIGN: We conducted a retrospective observational study from January 2011 to August 2012. SETTING: This was a monocentric study at the Department of Internal Medicine, Bichat Hospital, Paris-Diderot University, Paris, France. PARTICIPANTS: Sixty consecutive patients who were receiving long-term prednisone therapy for systemic inflammatory disorders and in whom discontinuation of glucocorticoid treatment was planned. INTERVENTION: A short Synacthen test was performed. A bolus of 0.25 mg 1-24-ACTH was injected in the morning, 24 hours after the most recent dose of prednisone. Cortisol was measured at baseline and 60 minutes after Synacthen injection. MAIN OUTCOME MEASURES: We assessed frequency and risk estimate of pituitary-adrenal dysfunction. RESULTS: Twenty-nine patients (48.3%) had adrenal insufficiency defined by a plasmatic cortisol <100 nmol/L (n = 13) at baseline (time 0) or <550 nmol/L (n = 16) 60 minutes after Synacthen injection. Cumulative dose (area under the receiver operating characteristic curve = 0.77 [95% confidence interval = 0.62-0.91], P = .007) and exposure (area under the receiver operating characteristic curve 0.80 [95% confidence interval = 0.67-0.93], P = .002) to prednisone were predictive for adrenal insufficiency based on a T0 <100 nmol/L. Prednisone was stopped in 29 of 31 patients (93.5%) showing a normal response to short Synacthen test; none of these patients required hydrocortisone replacement with a mean follow-up of 10 (± 6) months. CONCLUSION: Adrenal insufficiency is frequent in patients treated with long-term glucocorticoids for systemic inflammatory disorders and is related to duration and cumulative dose of steroids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is certain that the administration of oral GCs, long-term and in high doses, may cause GC-induced AI [7,8,9,10].”
From Glucocorticoid withdrawal-an overview on when and how to diagnose adrenal insufficiency in clinical practice (2021) · cites this paper as [9]
Citations
Cites
Use of oral corticosteroids in the United Kingdom
van Staa, T. P. (2000) · QJM · doi:10.1093/qjmed/93.2.105 · Cited by 529
Clinical review 62: Laboratory assessment of adrenal insufficiency.
Grinspoon, S. K., & Biller, B. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962298 · Cited by 442
A RATIONAL APPROACH FOR ASSESSING THE HYPOTHALAMO-PITUITARY-ADRENAL AXIS
Stewart, P. M., Seckl, J. R., Corrie, J., Edwards, C. R. W., & Padfield, P. L. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92020-x · Cited by 418
Schlaghecke, R., Kornely, E., Santen, R. T., & Ridderskamp, P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260403 · Cited by 381
Natural History of Pituitary-Adrenal Recovery Following Long-Term Suppression with Corticosteroids1
GRABER, A. L., NEY, R. L., NICHOLSON, W. E., ISLAND, D. P., & LIDDLE, G. W. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-1-11 · Cited by 375
Diagnosis of Adrenal Insufficiency
Dorin, R. I., Qualls, C. R., & Crapo, L. M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-3-200308050-00009 · Cited by 374
Predisposing Factors for Adrenal Insufficiency
Bornstein, S. R. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804635 · Cited by 356
Hahner, S., Loeffler, M., Bleicken, B., Drechsler, C., Milovanovic, D., Fassnacht, M., Ventz, M., Quinkler, M., & Allolio, B. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0884 · Cited by 346
Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency
HÄGG, E., ASPLUND, K., & LITHNER, F. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb00780.x · Cited by 233
Clark, Neylon, Raggatt, Sheppard, & Stewart (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00555.x · Cited by 207
Cited by
Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis
Broersen, L. H. A., Pereira, A. M., Jørgensen, J. O. L., & Dekkers, O. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1218 · Cited by 456
Systemic glucocorticoid therapy and adrenal insufficiency in adults: a systematic review
Joseph, R. M., Hunter, A. L., Ray, D. W., & Dixon, W. G. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.03.001 · Cited by 179
“Four studies followed patients for at least 1 year and in these studies the percentage of patients with persisting AI ranged from 15% to 67% [13,14,73,75].”
Mathian, A., Pha, M., Haroche, J., Cohen-Aubart, F., Hié, M., Pineton de Chambrun, M., Boutin, T. H. D., Miyara, M., Gorochov, G., Yssel, H., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216303 · Cited by 164
Woods, C. P., Argese, N., Chapman, M., Boot, C., Webster, R., Dabhi, V., Grossman, A. B., Toogood, A. A., Arlt, W., Stewart, P. M., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0608 · Cited by 152
Di Dalmazi, G., Berr, C. M., Fassnacht, M., Beuschlein, F., & Reincke, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1401 · Cited by 139
The Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity
Lockett, J., Inder, W. J., & Clifton, V. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae008 · Cited by 135
Berr, C. M., Di Dalmazi, G., Osswald, A., Ritzel, K., Bidlingmaier, M., Geyer, L. L., Treitl, M., Hallfeldt, K., Rachinger, W., Reisch, N., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3632 · Cited by 99
“In exogenous CS, length and dose of glucocorticoid exposure are independent predictors of recovery of adrenal function (9).”
BackgroundBorresen, S. W., Klose, M., Baslund, B., Rasmussen, Å. K., Hilsted, L., Friis-Hansen, L., Locht, H., Hansen, A., Hetland, M. L., Lydolph, M. C., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0251 · Cited by 63
Pelewicz, K., & Miśkiewicz, P. (2021) · Diagnostics · doi:10.3390/diagnostics11040728 · Cited by 44
Peeters, B., Boonen, E., Langouche, L., & den Berghe, G. V. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.11.012 · Cited by 54
Aurón, M., & Raissouni, N. (2015) · Pediatrics in Review · doi:10.1542/pir.36-3-92 · Cited by 61
Group 2: Adrenal insufficiency: screening methods and confirmation of diagnosis
Chanson, P., Guignat, L., Goichot, B., Chabre, O., Samara‐Boustani, D., Reynaud, R., Simon, D., Tabarin, A., Gruson, D., Reznik, Y., et al. (2017) · Annales d Endocrinologie · doi:10.1016/j.ando.2017.10.005 · Cited by 43
Adrenocortical Stress Response during the Course of Critical Illness
Peeters, B., Langouche, L., & Van den Berghe, G. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c170022 · Cited by 39
Schuetz, P., Leuppi, J. D., Bingisser, R., Bodmer, M., Briel, M., Drescher, T., Duerring, U., Henzen, C., Leibbrandt, Y., Maier, S., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0182 · Cited by 35
Cortisol metabolism in critical illness: implications for clinical care
Boonen, E., & den Berghe, G. V. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000066 · Cited by 47
“This condition resembles that of patients treated with exogenous glucocorticoids for an extended time, who also reveal a suppressed response to ACTH injection [37].”
BackgroundBorresen, S. W., Thorgrimsen, T. B., Jensen, B., Hilsted, L., Bartels, E. M., Feldt‐Rasmussen, U., & Locht, H. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa011 · Cited by 31
Boonen, E., & den Berghe, G. V. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1098 · Cited by 30
Valentin, A., Borresen, S. W., Rix, M., Elung‐Jensen, T., Sørensen, S. S., & Feldt‐Rasmussen, U. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz180 · Cited by 22
Stewart, P. M., & Newell-Price, J. D. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00015-0 · Cited by 35
Adrenocortical dysfunction in rheumatoid arthritis: Α narrative review and future directions
Filippa, M. G., Tektonidou, M. G., Mantzou, A., Kaltsas, G., Chrousos, G. P., Sfikakis, P. P., & Yavropoulou, M. P. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13635 · Cited by 21
Züger, T., Jordi, M., Laimer, M. W., & Stettler, C. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.13987 · Cited by 18
Wood, B. R., Lacy, J. M., Johnston, C., Weigle, D. S., & Dhanireddy, S. (2015) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/2325957414567681 · Cited by 17
“An attempt should be made to taper the corticosteroid medication slowly by monitoring for symptoms, recognizing that it can take a year or longer for return of normal function.(17) While some authors have suggested measuring serum cortisol every 4 to 6 weeks to determine whether continued steroid replacement is needed…”
BackgroundMethodSerban, A. L., Sala, E., Carosi, G., Sindaco, G. D., Giavoli, C., Locatelli, M., Arosio, M., Mantovani, G., & Ferrante, E. (2019) · Neuroendocrinology · doi:10.1159/000496846 · Cited by 19
The Recovery of Hypothalamic-Pituitary-Adrenal Axis Is Rapid in Subclinical Cushing Syndrome
Kim, H. K., Yoon, J. H., Jeong, Y. A., & Kang, H. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.4.592 · Cited by 15
Nanzer, A. M., Chowdhury, A. B., Raheem, A., Roxas, C., FERNANDES, M. R., Thomson, L., Green, L., Dhariwal, J., d’Ancona, G., Kent, B. D., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.02273-2019 · Cited by 17
Salehmohamed, M. R., Griffin, M., Branigan, T. B., Cuesta, M., & Thompson, C. J. (2017) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-017-1607-y · Cited by 14
“A recent study of patients treated with 7 mg of prednisone daily for systemic inflammatory disorders showed that 50% had evidence of adrenal suppression as defined by low baseline serum cortisol and/or subnormal responses to synacthen; those who failed the synacthen test had longer mean duration of steroid therapy [11…”
BackgroundClinical Factors Associated with Biochemical Adrenal-cortisol Insufficiency in Hospitalized Patients
Ben-Shlomo, A., Mirocha, J., Gwin, S. M., Khine, A. K., Liu, N., Sheinin, R. C., & Melmed, S. K. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.03.002 · Cited by 12
“Although endogenous adrenal-cortisol insufficiency is rare, glucocorticoid treatment-induced adrenal insufficiency may be more prevalent (4), as 2.”
BackgroundGlucocorticoid Withdrawal Symptoms and Quality of Life in Patients with Systemic Lupus Erythematosus
Karoonkatima, M., Narongroeknawin, P., Chaiamnuay, S., Asavatanabodee, P., & Pakchotanon, R. (2023) · International Journal of Rheumatology · doi:10.1155/2023/5750791 · Cited by 9
“This might be the end tail of withdrawal regimen, and HPA axis was recovering as mentioned in previous studies [17, 19, 21].”
ResultHarbeck, B., Danneberg, S., Rahvar, A., Haas, C. S., Lehnert, H., Kropp, P. A., & Mönig, H. (2016) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-016-9338-9 · Cited by 9
“While previous findings have shown that prolonged glucocorticoid exposure is a major determinant for adverse side effects (Bomberg et al. 2015; Sacre et al. 2013) and may create deficits in memory and attention both during and after treatment (Wolkowitz et al. 2007), only few data is available…”
BackgroundVaiani, E., Maceiras, M., Chaler, E., Lazzati, J. M., Chiavero, M., Novelle, C., Rivarola, M., & Belgorosky, A. (2014) · Hormone Research in Paediatrics · doi:10.1159/000368318 · Cited by 8
Komminoth, M., Donath, M. Y., Hepprich, M., Schüetz, P., Blum, C. A., Müeller, B., Reny, J., Gosselin, P., Bréville, G., Brändle, M., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281585 · Cited by 11
Pokrzywa, A., Ambroziak, U., Foroncewicz, B., Macech, M., Pączek, L., Florczak, M., Mucha, K., & Bednarczuk, T. (2019) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.15091 · Cited by 8
Ritter, A., Burow, A., Vallelian, F., & Schaer, D. J. (2014) · Praxis · doi:10.1024/1661-8157/a001747 · Cited by 5
Corticotrophins, Corticosteroids, and Prostaglandins
Brophy, A., & Ray, S. D. (2015) · Side effects of drugs annual · doi:10.1016/bs.seda.2015.05.004 · Cited by 4
New concepts to further unravel adrenal insufficiency during critical illness
Boonen, E., & den Berghe, G. V. (2016) · Cited by 3
Administering steroids with HIV treatment‐boosting agents
Singh, G. K. J., Jones, R., & Shotliff, K. (2017) · Prescriber · doi:10.1002/psb.1599 · Cited by 3
Adrenal insufficiency in pediatric kidney transplantation recipients
Chae, H. H., Ahmed, A., Bone, J. N., Abdulhussein, F. S., Amed, S., Patel, T., & Blydt‐Hansen, T. D. (2024) · Pediatric Transplantation · doi:10.1111/petr.14768 · Cited by 3
Cushing’s Disease, Refining the Definition of Remission and Recurrence
Ciporen, J. N., Cetas, J. S., McCartney, S., & Fleseriu, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_12 · Cited by 2
Adrenal insufficiency in giant cell arteritis
Ducker, G., Dhatariya, K., & Mukhtyar, C. B. (2025) · Rheumatology Advances in Practice · doi:10.1093/rap/rkaf050 · Cited by 1
Kim, J., & Gwak, H. (2015) · Clinics in Shoulder and Elbow · doi:10.5397/cise.2015.18.2.80 · Cited by 1
Pituitary-Adrenal Axis Suppression After Long-Term Prednisone Use
Brett, A. S. (2013) · Journal watch · doi:10.1056/nejm-jw.na32002
Clinical Management of Dystrophinopathies
Guglieri, M., & Bushby, K. M. D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-417044-5.00031-7 · Cited by 3
Managing Adrenal Insufficiency and Crisis
Puar, T. H. K., & Jeyaraman, K. (2018) · Springer eBooks · doi:10.1007/978-981-10-1124-5_34 · Cited by 2
Glucocorticoid Withdrawal in Lupus Nephritis: A Study Protocol and Literature Review
Ciang, N. C.-O., & Mok, C. C. (2020) · Journal of Clinical Rheumatology and Immunology · doi:10.1142/s2661341720300049
Safety and Efficacy of One Week Oral Steroid Therapy in the Treatment of Common Eczemas
Saoji, V. A., & Bhat, A. (2020) · Indian Journal of Drugs in Dermatology · doi:10.4103/ijdd.ijdd_64_20
Misaki, M., & Komagamine, J. (2020) · Research Square · doi:10.21203/rs.3.rs-33309/v1
(2022) · Journal of Clinical Images and Medical Case Reports · doi:10.52768/2766-7820/2040
Factors influencing steroid withdrawal syndrome in very-low-birth-weight infantsPreprint
Koike, Y., Inoue, M., Tsushita, H., Tanaka, R., Takumi, Y., Ono, H., Tatsuta, R., Kishimoto, S., Maeda, T., Itoh, H., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6437533/v1
Tessier, B. (2020) · theses.fr (ABES) · doi:10.70675/aa11b9e0z7678z408az8f88zc6c7c48df60f · Cited by 1
Wu, Z., Zeng, S., Qi, Y., Huang, W., Wang, Q., Chen, Z., Zhuo, J., Huang, H., Li, W., Liu, D., et al. (2026) · Materials & Design · doi:10.1016/j.matdes.2026.117355
Metadata
- Authors
- Sacre, K., Dehoux, M., Chauveheid, M. P., Chauchard, M., Lidove, O., Roussel, R., & Papo, T.
- Affiliations
- Groupe Hospitalier Diaconesses Croix Saint-Simon (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Corresponding author
- Papo, T.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-08
- Volume
- 98
- Issue
- 8
- Pages
- 3199-3205
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2158013717
- Cited by
- 52
- References
- 25
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 6 · 2019: 4 · 2018: 2 · 2017: 5 · 2016: 8 · 2015: 7 · 2014: 9 · 2013: 1
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- glucocorticoid-induced adrenal insufficiency, pituitary-adrenal axis, prednisone, long-term corticosteroid therapy, systemic inflammatory disease, ACTH stimulation test, cumulative glucocorticoid dose, hydrocortisone replacement, adrenal function testing, corticosteroid withdrawal, Cushing's syndrome, Cushing's disease
- MeSH terms
- Adrenal Insufficiency, Adult, Aged, Female, Follow-Up Studies, Glucocorticoids, Humans, Hydrocortisone, Inflammation, Male, Middle Aged, Pituitary-Adrenal System, Prednisone, Retrospective Studies, ROC Curve
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.